Qihan secures new funding
March 30, 2021- Share:
Qihan Biotechnology has added $67 million to its Series A round. Investors including Lilly Asia Ventures, Matrix Partners China, Sequoia and CMB International supported the funding. Based in Hangzhou, China, the company is using genome editing technology to develop cell therapies and organs for transplantation.
- Share:
-
-
-
-